[
  {
    "date": "2023-12-30",
    "symbol": "BCAB",
    "period": "FY",
    "netincomeloss": -123462000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "entityregistrantname": "BIOATLA, INC.",
    "entitycentralindexkey": 1826892,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "BCAB",
    "securityexchangename": "NASDAQ",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-39787",
    "entitytaxidentificationnumber": "85-1922320",
    "entityaddressaddressline1": "11085 Torreyana Road",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "558-0708",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Diego, CaliforniaMarch",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 111471000,
    "prepaidexpenseandotherassetscurrent": 4935000,
    "assetscurrent": 116406000,
    "propertyplantandequipmentnet": 1603000,
    "operatingleaserightofuseasset": 1495000,
    "otherassetsnoncurrent": 154000,
    "assets": 119658000,
    "accountspayableandaccruedliabilitiescurrent": 26720000,
    "operatingleaseliabilitycurrent": 1624000,
    "liabilitiescurrent": 28344000,
    "operatingleaseliabilitynoncurrent": 836000,
    "liabilitytolicensor": 19806000,
    "liabilities": 48986000,
    "commonstockvalue": 5000,
    "additionalpaidincapital": 486930000,
    "retainedearningsaccumulateddeficit": -416263000,
    "stockholdersequity": 70672000,
    "liabilitiesandstockholdersequity": 119658000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 200000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 350000000,
    "commonstocksharesissued": 48077599,
    "commonstocksharesoutstanding": 48077599,
    "researchanddevelopmentexpense": 103731000,
    "generalandadministrativeexpense": 25956000,
    "operatingexpenses": 129687000,
    "operatingincomeloss": -129687000,
    "investmentincomeinterest": 6312000,
    "otherincomeexpense": -87000,
    "othernonoperatingincomeexpense": 6225000,
    "earningspersharebasic": -2.58,
    "earningspersharediluted": -2.58,
    "weightedaveragenumberofsharesoutstandingbasic": 47777568,
    "weightedaveragenumberofdilutedsharesoutstanding": 47777568,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 5000,
    "sharesoutstanding": 48077599,
    "stockissuedduringperiodsharessharebasedcompensation": 318634,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 336000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 165550,
    "issuanceofcommonstockfordirectorcompensationvalue": 107000,
    "issuanceofcommonstockfordirectorcompensationshares": 45290,
    "taxesrelatedtonetsharesettlementofequityawards": -192000,
    "stockissuedduringperiodsharesconversionofclassbcommonstock": 1211959,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13544000,
    "depreciationdepletionandamortization": 1221000,
    "gainlossonsaleofpropertyplantequipment": -2000,
    "sharebasedcompensation": 13544000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 11000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 5284000,
    "increasedecreaseinoperatingleaseliability": -593000,
    "netcashprovidedbyusedinoperatingactivities": -104015000,
    "paymentstoacquiremachineryandequipment": 98000,
    "netcashprovidedbyusedininvestingactivities": -98000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 336000,
    "paymentsfortaxesrelatedtonetsettlementofequityawards1": 259000,
    "netcashprovidedbyusedinfinancingactivities": 77000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -104036000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 111471000,
    "taxrelatedtonetsettlementofequityawardincludedinaccountspayableandaccruedexpenses": 6000,
    "companyformationdate": "2007-03",
    "uncertaintaxpositionspercentage": 0.5,
    "cashandcashequivalents": 50400000,
    "accruedclinicaltrialcosts": 12500000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6273507,
    "prepaidresearchanddevelopmentexpense": 4615000,
    "otherprepaidexpensesandcurrentassets": 320000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentgross": 1721000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6078000,
    "accountspayablecurrent": 3819000,
    "accruedsalariescurrent": 3790000,
    "accruedresearchanddevelopmentexpensecurrent": 18246000,
    "otheraccruedliabilitiescurrent": 865000,
    "restrictedcashequivalents": 50400000,
    "lessoroperatingleasesoptiontoextend": "P5Y",
    "lessoroperatingleaseoptiontoextend": "The lease expires in July 2025 and the Company has an option to extend the term of the lease for an additional five years. Additionally, the lease includes certain rent abatement, rent escalations, tenant improvement allowances and additional charges for common area maintenance and other costs.",
    "operatingleasecost": 1043000,
    "variableleasecost": 544000,
    "leasecost": 1587000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.035,
    "operatingleasepayments": 1500000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1685000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 845000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2530000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 70000,
    "operatingleaseliability": 2460000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 45290,
    "compensationexpenseonissuanceofdirectorcompensation": 100000,
    "conversionofstockdescription": "Holders of the Company’s common stock have no conversion rights, while holders of the Company’s Class B common stock shall have the right to convert each share of Class B common stock into one share of common stock at such holder’s election, provided that as a result of such conversion, such holder would not beneficially own in excess of 4.99% of any class of the Company’s securities registered under the Securities Exchange Act of 1934",
    "periodrelatedtochangingofownershiplimitationpercentagedesignatedbyclassbcommonstockholder": "P61D",
    "commonstockvotingrights": "one",
    "commonsharesauthorizedforissuance": 9196970,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P36M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The warrants became exercisable upon the Company's IPO for a period of 365 and 450 days",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 6700000,
    "totalnumberofmodifiedunvestedrestrictedstockunits": 139730,
    "totalnumberofmodifiedunvestedoptions": 574244,
    "compensationcostforthemodifiedunvestedoptions": 962000,
    "compensationcostforthemodifiedunvestedrestrictedstockunits": 416000,
    "numberofmodifiedfullyvestedoptions": 130699,
    "increaseincompensationcostoffullyvestedoptions": 123000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 1800,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P0Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "increaseincommonstockauthorizedforissuance": 929658,
    "commonstockcapitalsharesreservedforfutureissuance": 8776826,
    "employeebenefitsandsharebasedcompensation": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 99104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 45290,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 22277,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 16.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6273507,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4020395,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 371439,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 112367,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1429449,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6273507,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.74,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 20.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 7.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 74680000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 74680000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2007000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.779,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0389,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y18D",
    "stockissuedduringperiodsharesrestrictedstockawardgross": 991413,
    "extendedrentagreement": "P12M",
    "proceedsfromissuanceofprivateplacement": 19100000,
    "optionsgrantsrelatedtoroyaltypaymentperiod": "P10Y",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -25927000,
    "stateincometaxesnetoffederaltaxbenefit": -8000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 99000,
    "allocatedsharebasedcompensationexpensenetoftax": 1326000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 6205000,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 1551000,
    "incometaxreconciliationnondeductibleexpenseother": 228000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 28936000,
    "deferredtaxassetsoperatinglosscarryforwards": 25034000,
    "deferredtaxliabilitynotrecognizedamountofunrecognizeddeferredtaxliabilitybaddebtreservefortaxpurposesofqualifiedlender": 4159000,
    "deferredtaxassetsgoodwillandintangibleassets": 2938000,
    "leaseliability": 517000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeecompensation": 746000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10379000,
    "section174costcapitalization": 31220000,
    "section59ecostcapitalization": 8400000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2790000,
    "deferredtaxassetsother": 4000,
    "deferredtaxassetsgross": 86187000,
    "deferredtaxassetsvaluationallowance": 85642000,
    "deferredtaxassetsnet": 545000,
    "deferredtaxliabilitiesregulatoryassets": 231000,
    "deferredtaxliabilitiesleasingarrangements": 314000,
    "deferredtaxliabilities": 545000,
    "valuationallowancedeferredtaxassetchangeinamount": 28900000,
    "federalnetoperatinglosscarryforward": 119200000,
    "statenetoperatinglosscarryforwards": 200000,
    "taxcreditcarryforwardamount": 7800000,
    "orphandrugcredit": 3900000,
    "operatinglosscarryforwardsexpirationperiod": 2040,
    "orphandrugcreditcarryforwardsexpirationperiod": 2041,
    "annualoperatinglosscarryforwardsuse": "Sections 382 and 383, annual use of the Company’s net operating loss carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.",
    "caresactnolcarryovercarrybackoffsettotaxableincome": 0.5,
    "unrecognizedtaxbenefits": 3602000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 161000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1473000
  },
  {
    "date": "2022-12-30",
    "symbol": "BCAB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "entityregistrantname": "BIOATLA, INC.",
    "entitycentralindexkey": 1826892,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "BCAB",
    "securityexchangename": "NASDAQ",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-39787",
    "entitytaxidentificationnumber": "85-1922320",
    "entityaddressaddressline1": "11085 Torreyana Road",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "558-0708",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Diego, CaliforniaMarch",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 215507000,
    "prepaidexpenseandotherassetscurrent": 4924000,
    "assetscurrent": 220431000,
    "propertyplantandequipmentnet": 2728000,
    "operatingleaserightofuseasset": 2423000,
    "otherassetsnoncurrent": 154000,
    "assets": 225736000,
    "accountspayableandaccruedliabilitiescurrent": 21610000,
    "operatingleaseliabilitycurrent": 1521000,
    "liabilitiescurrent": 23131000,
    "operatingleaseliabilitynoncurrent": 2460000,
    "liabilitytolicensor": 19806000,
    "liabilities": 45397000,
    "commonstockvalue": 5000,
    "additionalpaidincapital": 473135000,
    "retainedearningsaccumulateddeficit": -292801000,
    "stockholdersequity": 180339000,
    "liabilitiesandstockholdersequity": 225736000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 200000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 350000000,
    "commonstocksharesissued": 46336166,
    "commonstocksharesoutstanding": 46336166,
    "researchanddevelopmentexpense": 79347000,
    "generalandadministrativeexpense": 28793000,
    "operatingexpenses": 108140000,
    "operatingincomeloss": -108140000,
    "investmentincomeinterest": 1648000,
    "otherincomeexpense": 10000,
    "othernonoperatingincomeexpense": 1658000,
    "netincomeloss": -106482000,
    "earningspersharebasic": -2.74,
    "earningspersharediluted": -2.74,
    "weightedaveragenumberofsharesoutstandingbasic": 38927268,
    "weightedaveragenumberofdilutedsharesoutstanding": 38927268,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 5000,
    "sharesoutstanding": 46336166,
    "stockissuedduringperiodsharessharebasedcompensation": 364141,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 289000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 147564,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 9745128,
    "taxesrelatedtonetsharesettlementofequityawards": -534000,
    "stockissuedduringperiodsharesconversionofclassbcommonstock": 280100,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 14563000,
    "paymentsofstockissuancecosts": 3318000,
    "depreciationdepletionandamortization": 1199000,
    "gainlossonsaleofpropertyplantequipment": -13000,
    "sharebasedcompensation": 14563000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2611000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 3411000,
    "increasedecreaseinoperatingleaseliability": -513000,
    "netcashprovidedbyusedinoperatingactivities": -90420000,
    "paymentstoacquiremachineryandequipment": 268000,
    "proceedsfromsaleofotherpropertyplantandequipment": 3000,
    "netcashprovidedbyusedininvestingactivities": -265000,
    "proceedsfromissuanceofcommonstock": 61682000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 289000,
    "paymentsfortaxesrelatedtonetsettlementofequityawards1": 758000,
    "netcashprovidedbyusedinfinancingactivities": 61213000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -29472000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 215507000,
    "propertyplantandequipmentadditions": 1000,
    "taxrelatedtonetsettlementofequityawardincludedinaccountspayableandaccruedexpenses": 67000,
    "companyformationdate": "2007-03",
    "uncertaintaxpositionspercentage": 0.5,
    "numberofoperatingsegments": 1,
    "accruedclinicaltrialcosts": 5500000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2736918,
    "prepaidresearchanddevelopmentexpense": 4385000,
    "otherprepaidexpensesandcurrentassets": 539000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentgross": 2140000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5364000,
    "accountspayablecurrent": 4231000,
    "accruedsalariescurrent": 3451000,
    "accruedresearchanddevelopmentexpensecurrent": 12649000,
    "otheraccruedliabilitiescurrent": 1279000,
    "debtconversiondescription": "The Company did not have any outstanding debt as of December 31, 2022 or December 31, 2021. In April 2020, the Company borrowed $0.7 million under the Paycheck Protection Program (“PPP”) under the CARES Act. The loan was subsequently forgiven in July 2021. The $0.7 million balance of the forgiven loan was recognized as other income on the Company's Statement of Operations and Comprehensive Loss for the twelve months ended December 31, 2021",
    "operatingleasecost": 1043000,
    "variableleasecost": 460000,
    "leasecost": 1503000,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.035,
    "operatingleasepayments": 1555000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1636000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1685000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 845000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4166000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 184000,
    "operatingleaseliability": 3982000,
    "conversionofstockdescription": "Holders of the Company’s common stock have no conversion rights, while holders of the Company’s Class B common stock shall have the right to convert each share of Class B common stock into one share of common stock at such holder’s election, provided that as a result of such conversion, such holder would not beneficially own in excess of 4.99% of any class of the Company’s securities registered under the Securities Exchange Act of 1934",
    "periodrelatedtochangingofownershiplimitationpercentagedesignatedbyclassbcommonstockholder": "P61D",
    "commonstockvotingrights": "one",
    "commonsharesauthorizedforissuance": 7658509,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P36M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The warrants became exercisable upon our IPO for a period of 365 and 450 days",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 6900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 510039,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9200,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsotherincreasesdecreasesinperiod": 929658,
    "commonstockcapitalsharesreservedforfutureissuance": 1070402,
    "employeebenefitsandsharebasedcompensation": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 446260,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 18747,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2736918,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1718200,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 50387,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 17797,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 496074,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2736918,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.82,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 21.64,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 40,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 25.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 13.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y9M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y9M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3636148000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3636148000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.749,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0214,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y14D",
    "stockissuedduringperiodsharesrestrictedstockawardgross": 3012554,
    "collaborationagreementstartdate": "2021-11",
    "proceedsfromissuanceofprivateplacement": 19100000,
    "optionsgrantsrelatedtoroyaltypaymentperiod": "P10Y",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -22361000,
    "stateincometaxesnetoffederaltaxbenefit": -6000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 685000,
    "allocatedsharebasedcompensationexpensenetoftax": -1132000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 3692000,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 910000,
    "incometaxreconciliationnondeductibleexpenseother": -23000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 23355000,
    "deferredtaxassetsoperatinglosscarryforwards": 17430000,
    "deferredtaxliabilitynotrecognizedamountofunrecognizeddeferredtaxliabilitybaddebtreservefortaxpurposesofqualifiedlender": 4159000,
    "deferredtaxassetsgoodwillandintangibleassets": 3193000,
    "leaseliability": 836000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeecompensation": 659000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 5760000,
    "section174costcapitalization": 14523000,
    "section59ecostcapitalization": 9450000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1628000,
    "deferredtaxassetsother": 3000,
    "deferredtaxassetsgross": 57641000,
    "deferredtaxassetsvaluationallowance": 56706000,
    "deferredtaxassetsnet": 935000,
    "deferredtaxliabilitiesregulatoryassets": 426000,
    "deferredtaxliabilitiesleasingarrangements": 509000,
    "deferredtaxliabilities": 935000,
    "valuationallowancedeferredtaxassetchangeinamount": 23400000,
    "federalnetoperatinglosscarryforward": 83000000,
    "statenetoperatinglosscarryforwards": 200,
    "taxcreditcarryforwardlimitationsonuse": "The federal and state net operating losses can be carried forward indefinitely, subject to an 80% limitation against taxable income.",
    "taxcreditcarryforwardamount": 3700000,
    "orphandrugcredit": 2300000,
    "operatinglosscarryforwardsexpirationperiod": 2040,
    "orphandrugcreditcarryforwardsexpirationperiod": 2041,
    "annualoperatinglosscarryforwardsuse": "Sections 382 and 383, annual use of the Company’s net operating loss carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.",
    "caresactnolcarryovercarrybackoffsettotaxableincome": 0.5,
    "proceedsfromloans": 700000,
    "unrecognizedtaxbenefits": 1968000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 11000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 946000
  },
  {
    "date": "2021-12-30",
    "symbol": "BCAB",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "Delaware",
    "entityregistrantname": "BIOATLA, INC.",
    "entitycentralindexkey": 1826892,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "BCAB",
    "securityexchangename": "The Nasdaq Global Market",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "true",
    "entityfilenumber": "001-39787",
    "entitytaxidentificationnumber": "85-1922320",
    "entityaddressaddressline1": "11085 Torreyana Road",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "558-0708",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "true",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 244979000,
    "prepaidexpenseandotherassetscurrent": 2313000,
    "assetscurrent": 247292000,
    "propertyplantandequipmentnet": 3676000,
    "operatingleaserightofuseasset": 3300000,
    "otherassetsnoncurrent": 154000,
    "assets": 254422000,
    "accountspayableandaccruedliabilitiescurrent": 18424000,
    "operatingleaseliabilitycurrent": 1389000,
    "liabilitiescurrent": 19813000,
    "operatingleaseliabilitynoncurrent": 3982000,
    "liabilitytolicensor": 19800000,
    "liabilities": 43601000,
    "commonstockvalue": 4000,
    "additionalpaidincapital": 397136000,
    "retainedearningsaccumulateddeficit": 186300000,
    "stockholdersequity": 210821000,
    "liabilitiesandstockholdersequity": 254422000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 833993,
    "commonstocksharesissued": 625000,
    "commonstocksharesoutstanding": "null",
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 250000,
    "researchanddevelopmentexpense": 58274000,
    "generalandadministrativeexpense": 38416000,
    "operatingexpenses": 96690000,
    "operatingincomeloss": -96440000,
    "investmentincomeinterest": 350000,
    "interestexpense": 3000,
    "gainslossesonextinguishmentofdebt": 2700000,
    "otherincomeexpense": 1000,
    "othernonoperatingincomeexpense": 1038000,
    "netincomeloss": -95402000,
    "netincomelossconsolidatednetlossandcomprehensiveloss": -95402000,
    "earningspersharebasicanddiluted": -2.76,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 210821000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodsharessharebasedcompensation": 930144,
    "stockissuedduringperiodvaluestockoptionsexercised": 140000,
    "stockissuedduringperiodsharesstockoptionsexercised": 7747,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 289000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 11182,
    "stockissuedduringperiodvaluenewissues": 70994000,
    "stockissuedduringperiodsharesnewissues": "null",
    "taxrelatedtonetsettlementofequityawardsincludedinaccountspayableandaccruedexpenses": -291000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 25117000,
    "paymentsofstockissuancecosts": 4007000,
    "depreciationdepletionandamortization": 1330000,
    "gainlossonsaleofpropertyplantequipment": -4000,
    "sharebasedcompensation": 9400000,
    "increasedecreaseinaccruedinterestreceivablenet": -3000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 237000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 7992000,
    "increasedecreaseinoperatingleaseliability": -331000,
    "netcashprovidedbyusedinoperatingactivities": -62214000,
    "paymentstoacquiremachineryandequipment": 924000,
    "netcashprovidedbyusedininvestingactivities": -924000,
    "paymentsforrepurchaseofinitialpublicoffering": 1911000,
    "proceedsfromissuanceofcommonstock": 70994000,
    "proceedsfromstockoptionsexercised": 140000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 289000,
    "netcashprovidedbyusedinfinancingactivities": 69512000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 6374000,
    "propertyplantandequipmentadditions": 1000,
    "companyformationdate": "March 2007",
    "commonunitissued": "null",
    "uncertaintaxpositionspercentage": 0.5,
    "numberofoperatingsegments": 1,
    "preferredstockdividendratepercentage": 0.1,
    "accruedclinicaltrialcosts": 6200000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "prepaidresearchanddevelopmentexpense": 1811000,
    "otherprepaidexpensesandcurrentassets": 502000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentgross": 7933000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 4257000,
    "accountspayablecurrent": 1179000,
    "accruedsalariescurrent": 2671000,
    "accruedresearchanddevelopmentexpensecurrent": 13501000,
    "otheraccruedliabilitiescurrent": 1073000,
    "stockissuedduringperiodvalueconversionofconvertiblesecuritiesnetofadjustments": 30600000,
    "debtinstrumentdecreaseforgiveness": 700000,
    "lessoroperatingleasesoptiontoextend": "five years",
    "lessoroperatingleaseoptiontoextend": "The lease expires in July 2025 and the Company has an option to extend the term of the lease for an additional five years. However, it is not reasonably certain the Company will exercise the option to renew when the lease term ends and thus, the incremental term was excluded from the calculation of the lease liability. Additionally, the ",
    "operatingleaseexpense": 1700000,
    "operatingleaserightofuseassettotal": 3300000,
    "operatingleaseliability": 5371000,
    "operatingleasecost": 1043000,
    "variableleasecost": 512000,
    "leasecost": 1555000,
    "operatingleaseweightedaverageremainingleaseterm1": 3.5,
    "operatingleaseweightedaveragediscountratepercent": 0.035,
    "operatingleasepayments": 1374000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1555000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1636000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1685000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 845000,
    "lesseeoperatingleaseliabilitypaymentsdue": 5721000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 350000,
    "conversionofstockdescription": "Holders of the Company’s common stock have no conversion rights, while holders of the Company’s Class B common stock shall have the right to convert each share of Class B common stock into one share of common stock at such holder’s election, provided that as a result of such conversion, such holder would not beneficially own in excess of 4.99% of any class of the Company’s securities registered under the Securities Exchange Act of 1934",
    "periodrelatedtochangingofownershiplimitationpercentagedesignatedbyclassbcommonstockholder": 61,
    "commonstockvotingrights": "one",
    "warrantsexpiredandunexercised": 566586,
    "commonsharesauthorizedforissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 975046,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 15000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 24.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsotherincreasesdecreasesinperiod": 929658,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "outstandingandexercisablecommonstockwarrants": 151088,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 18.31,
    "commonstockwarrantsexpirationdate": "March 12, 2022",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 944991,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 479543,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 155579,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 26.76,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 37.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 26.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 9.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 9.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 8.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 991495000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 182829000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 991495000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 247486000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.747,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0106,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.98,
    "warrantsforthepurchaseofcommonstock": 151088,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 822811,
    "collaborationagreementstartdate": "2020-10",
    "revenues": 300000,
    "collaborationagreementenddate": "2019-12",
    "collaborationagreementdurationperiod": "four-year",
    "debtinstrumentfaceamount": 500000,
    "debtinstrumentsettleddate": "July 2020",
    "incrementalfairvalue": 7000000,
    "lumpsumsalarypaymentandtargetbonus": 1000000,
    "proceedsfromissuanceofprivateplacement": 17500000,
    "optionsgrantsrelatedtoroyaltypaymentperiod": "10 years",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -20034000,
    "incometaxexpensebenefitcontinuingoperationsadjustmentofdeferredtaxassetliability": -2131000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 4145000,
    "allocatedsharebasedcompensationexpensenetoftax": 1021000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 3091000,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 757000,
    "incometaxreconciliationnondeductibleexpenseother": 793000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 20582000,
    "deferredtaxassetsoperatinglosscarryforwards": 21935000,
    "deferredtaxliabilitynotrecognizedamountofunrecognizeddeferredtaxliabilitybaddebtreservefortaxpurposesofqualifiedlender": 4159000,
    "deferredtaxassetsgoodwillandintangibleassets": 3449000,
    "leaseliability": 1128000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeecompensation": 485000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2945000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 697000,
    "deferredtaxassetsother": 2000,
    "deferredtaxassetsgross": 34800000,
    "deferredtaxassetsvaluationallowance": 33351000,
    "deferredtaxassetsnet": 1449000,
    "deferredtaxliabilitiesregulatoryassets": 756000,
    "deferredtaxliabilitiesleasingarrangements": 693000,
    "deferredtaxliabilities": 1449000,
    "valuationallowancedeferredtaxassetchangeinamount": 20600000,
    "federalnetoperatinglosscarryforward": 104500000,
    "taxcreditcarryforwardlimitationsonuse": "The federal net operating losses can be carried forward indefinitely, subject to an 80% limitation against taxable income.",
    "taxcreditcarryforwardamount": 1200000,
    "orphandrugcredit": 1000000,
    "operatinglosscarryforwardsexpirationperiod": 2040,
    "orphandrugcreditcarryforwardsexpirationperiod": 2041,
    "annualoperatinglosscarryforwardsuse": "Sections 382 and 383, annual use of the Company’s net operating loss carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.",
    "caresactnolcarryovercarrybackoffsettotaxableincome": 0.5,
    "proceedsfromloans": 700000,
    "unrecognizedtaxbenefits": 1011000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 801000
  }
]